Cambridge University scientists make stem cell breakthrough

Date posted: 25 Aug 2009

Researchers at a University of Cambridge centre have made a breakthrough relating to how stem cells develop, which could improve their use in future medical applications.

Academics working at the university's Wellcome Trust Centre believe they have discovered the final step in the process that sees embryonic stem cells change into other kinds of bodily cell.

The group's findings, which have now been published in the journal Cell, add to recent developments in the stem cell research sector.

Researchers at a University of Cambridge centre have made a breakthrough relating to how stem cells develop, which could improve their use in future medical applications.

Academics working at the university's Wellcome Trust Centre believe they have discovered the final step in the process that sees embryonic stem cells change into other kinds of bodily cell.

The group's findings, which have now been published in the journal Cell, add to recent developments in the stem cell research sector.

Dr Jose Silva, one of the leaders on the Cambridge research, believes it is important stem cells are fully investigated to ensure future technologies can safely use them.

He added: "If we want to create efficient, safe and reliable ways of generating these cells for medical applications, we need to understand the process; our research provides additional clues as to how it occurs."

The research was funded through charitable and public sources and was developed in collaboration with the Wellcome Trust and the EC Framework 7 project EuroSyStem, along with the Biotechnology and Biological Sciences Research Council.

The Wellcome Trust is an independent charity aiming to improve health for both humans and animals.ADNFCR-2386-ID-19327443-ADNFCR

Date: 
25 Aug 2009
Sector: 
Market: 

Send to a friend

PatrickFarrant.jpg

Click here to email or call on 01223 225181.

Patrick Farrant

Partner

Our team work with a range of technology clients from early stage through to major deals such as the $500m collaboration and licensing deal between Argenta Discovery and AstraZeneca.
Learn more...